Related references
Note: Only part of the references are listed.Two-year reduction of dual-energy CT urate depositions during a treat-to-target strategy in gout in the NOR-Gout longitudinal study
Till Uhlig et al.
RHEUMATOLOGY (2022)
12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target
Till Uhlig et al.
RMD OPEN (2021)
Changes in the Presentation of Incident Gout and the Risk of Subsequent Flares: A Population-based Study over 20 Years
Mohanad M. Elfishawi et al.
JOURNAL OF RHEUMATOLOGY (2020)
Development of a prediction model for inpatient gout flares in people with comorbid gout
Kanon Jatuworapruk et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
2020 American College of Rheumatology Guideline for the Management of Gout
John D. FitzGerald et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study
Hilde Berner Hammer et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare
C. A. Janssen et al.
CLINICAL RHEUMATOLOGY (2019)
Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout
David Bursill et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
The challenges of gout flare reporting: mapping flares during a randomized controlled trial
Novell Teoh et al.
BMC RHEUMATOLOGY (2019)
Variability in the Reporting of Serum Urate and Flares in Gout Clinical Trials: Need for Minimum Reporting Requirements
Lisa K. Stamp et al.
JOURNAL OF RHEUMATOLOGY (2018)
Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysis
Lisa Stamp et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2018)
Validation of a Definition of Flare in Patients With Established Gout
Angelo L. Gaffo et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial
Michael Doherty et al.
LANCET (2018)
Work disability in gout: a population-based case-control study
Valgerdur Sigurdardottir et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
2016 updated EULAR evidence-based recommendations for the management of gout
P. Richette et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Gout A Roadmap to Approaches for Improving Global Outcomes
Nicola Dalbeth et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Serum Uric Acid and the Risk of Incident and Recurrent Gout: A Systematic Review
Aki Shiozawa et al.
JOURNAL OF RHEUMATOLOGY (2017)
Effects of Febuxostat in Early Gout A Randomized, Double-Blind, Placebo-Controlled Study
Nicola Dalbeth et al.
ARTHRITIS & RHEUMATOLOGY (2017)
The unclosing premature mortality gap in gout: a general population-based study
Mark C. Fisher et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Development of a Dual-Energy Computed Tomography Scoring System for Measurement of Urate Deposition in Gout
Sara Bayat et al.
ARTHRITIS CARE & RESEARCH (2016)
Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study
Chang-Fu Kuo et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Alcohol Quantity and Type on Risk of Recurrent Gout Attacks: An Internet-based Case-crossover Study
Tuhina Neogi et al.
AMERICAN JOURNAL OF MEDICINE (2014)
Outcome Measures in Acute Gout: A Systematic Literature Review
Nicola Dalbeth et al.
JOURNAL OF RHEUMATOLOGY (2014)
Long-term safety of pegloticase in chronic gout refractory to conventional treatment
Michael A. Becker et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Developing a provisional definition of flare in patients with established gout
Angelo L. Gaffo et al.
ARTHRITIS AND RHEUMATISM (2012)
Risk factors for gout and prevention: a systematic review of the literature
Jasvinder A. Singh et al.
CURRENT OPINION IN RHEUMATOLOGY (2011)
Work productivity loss due to flares in patients with chronic gout refractory to conventional therapy
N.L. Edwards et al.
JOURNAL OF MEDICAL ECONOMICS (2010)
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005
L. Annemans et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Clinical features and risk factors of postsurgical gout
E. H. Kang et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
EULAR evidence based recommendations for gout.: Part II:: Management.: Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT)
W. Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Febuxostat compared with allopurinol in patients with hyperuricemia and gout
MA Becker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: Evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy
A Shoji et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
The self-administered comorbidity questionnaire: A new method to assess comorbidity for clinical and health services research
O Sangha et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2003)
Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout
F Perez-Ruiz et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2002)
Share Paper
